Full Text
Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain

Abstract

Authors

J.L. Garcia Lopez Barrios J.M. Rodriguez J. Puig-Junoy Mena A. Carrato

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×